Treatment of depression in patients with Parkinson's disease

Trial Profile

Treatment of depression in patients with Parkinson's disease

Phase of Trial: Phase II

Latest Information Update: 26 Nov 2015

At a glance

  • Drugs Nortriptyline (Primary) ; Paroxetine (Primary)
  • Indications Depression; Dysthymic disorder; Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2011 Results published in the American Journal of Geriatric Psychiatry.
    • 08 Apr 2009 Change in protocol patients with psychosis and heart block as exclusion criteria added as reported by
    • 08 Apr 2009 GlaxoSmithKline reported as trial sponsor by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top